Corcept Therapeutics

Quarterly Financials

Values in thousands2025-09-302025-06-302025-03-312024-12-31
Revenue
$207,638
$194,430
$157,214
$181,890
Gross Profit
203,042
190,997
154,811
178,934
EBITDA
15,720
27,144
3,878
25,722
EBIT
15,243
26,675
3,416
25,262
Net Income
19,359
35,149
20,288
30,389
Net Change In Cash
207,638
194,430
157,214
181,890
Free Cash Flow
54,481
43,882
5,024
59,179
Cash
125,138
102,745
89,819
127,665
Basic Shares
119,439
120,485
119,819
118,459

Annual Financials

Values in thousands2024-12-312023-12-312022-12-312021-12-31
Revenue
$675,040
$482,375
$401,858
$365,978
Gross Profit
664,158
475,894
396,473
360,697
EBITDA
138,287
108,324
115,603
127,544
EBIT
136,951
107,282
112,634
124,477
Net Income
139,733
106,140
101,418
112,512
Net Change In Cash
675,040
482,375
401,858
365,978
Cost of Revenue
1,427
Free Cash Flow
195,895
126,900
119,910
167,423
Cash
127,665
135,551
66,329
77,617
Basic Shares
113,480
111,742
115,966
125,963

Earnings Calls

QuarterEPS
2025-12-31
$0
2025-09-30
$0.16
2025-06-30
$0.29
2025-03-31
$0.16